Sen. Charles Grassley, an Iowa Republican who is a leading critic of conflicts of interest in biomedical research, is focusing on the issue of journal ghostwriting. The New York Times reported that he has written to 10 medical schools, asking about whether they have policies that deal with issues raised by pharmaceutical companies ghostwriting articles that appear under the names of university researchers.
- Defining Accountability
- Senate Report Accuses Company of Manipulating Researchers' Studies
- 'The College Fear Factor'
- Flexible Fund Raising
- Be a Tech-Aware Adjunct
- Researchers' Financial Disclosures in the Spotlight
- Quick Takes: Advice for Obama/McCain, U.S. Poised to Keep Spending Flat, Obama in Effigy at George Fox, Defining the Bishop's Role, Lambuth President Steps Down, NIH Chief to Depart, Equity in Science Prizes, Drug Makers' Payments to Scientists
Search for Jobs